250 related articles for article (PubMed ID: 18486630)
1. NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action.
Rigas B; Williams JL
Nitric Oxide; 2008 Sep; 19(2):199-204. PubMed ID: 18486630
[TBL] [Abstract][Full Text] [Related]
2. Nitric-oxide-donating NSAIDs as agents for cancer prevention.
Rigas B; Kashfi K
Trends Mol Med; 2004 Jul; 10(7):324-30. PubMed ID: 15242680
[TBL] [Abstract][Full Text] [Related]
3. Development of novel agents based on nitric oxide for the control of colon cancer.
Kozoni V; Rosenberg T; Rigas B
Acta Pharmacol Sin; 2007 Sep; 28(9):1429-33. PubMed ID: 17723176
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-donating non-steroidal anti-inflammatory drugs: the case of nitroderivatives of aspirin.
Chiroli V; Benedini F; Ongini E; Del Soldato P
Eur J Med Chem; 2003 Apr; 38(4):441-6. PubMed ID: 12750033
[TBL] [Abstract][Full Text] [Related]
5. NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?
Yeh RK; Chen J; Williams JL; Baluch M; Hundley TR; Rosenbaum RE; Kalala S; Traganos F; Benardini F; del Soldato P; Kashfi K; Rigas B
Biochem Pharmacol; 2004 Jun; 67(12):2197-205. PubMed ID: 15163551
[TBL] [Abstract][Full Text] [Related]
6. Novel agents for cancer prevention based on nitric oxide.
Rigas B
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1364-8. PubMed ID: 17956352
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect.
Kashfi K; Rayyan Y; Qiao LL; Williams JL; Chen J; Del Soldato P; Traganos F; Rigas B; Ryann Y
J Pharmacol Exp Ther; 2002 Dec; 303(3):1273-82. PubMed ID: 12438552
[TBL] [Abstract][Full Text] [Related]
8. The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia.
Rigas B
Curr Opin Gastroenterol; 2007 Jan; 23(1):55-9. PubMed ID: 17133086
[TBL] [Abstract][Full Text] [Related]
9. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
Fiorucci S; Santucci L; Distrutti E
Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs.
Keeble JE; Moore PK
Br J Pharmacol; 2002 Oct; 137(3):295-310. PubMed ID: 12237248
[TBL] [Abstract][Full Text] [Related]
11. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
Velázquez C; Praveen Rao PN; Knaus EE
J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
[TBL] [Abstract][Full Text] [Related]
13. What's new in NSAID pharmacotherapy: oral agents to injectables.
Atkinson TJ; Fudin J; Jahn HL; Kubotera N; Rennick AL; Rhorer M
Pain Med; 2013 Dec; 14 Suppl 1():S11-7. PubMed ID: 24373105
[TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide in the gastrointestinal tract.
Lanas A
Arthritis Res Ther; 2008; 10 Suppl 2(Suppl 2):S4. PubMed ID: 19007429
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of action of nitric oxide-donating aspirin.
Kashfi K; Rigas B
Biochem Biophys Res Commun; 2007 Jul; 358(4):1096-101. PubMed ID: 17512900
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritis.
Mackenzie IS; Rutherford D; MacDonald TM
Arthritis Res Ther; 2008; 10 Suppl 2(Suppl 2):S3. PubMed ID: 19007428
[TBL] [Abstract][Full Text] [Related]
17. Effects of nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NONO-NSAIDs) on melanoma cell adhesion.
Cheng H; Mollica MY; Lee SH; Wang L; Velázquez-Martínez CA; Wu S
Toxicol Appl Pharmacol; 2012 Oct; 264(2):161-6. PubMed ID: 22889880
[TBL] [Abstract][Full Text] [Related]
18. Cyclo-oxygenase (COX) inhibiting nitric oxide donating (CINODs) drugs: a review of their current status.
Stefano F; Distrutti E
Curr Top Med Chem; 2007; 7(3):277-82. PubMed ID: 17305570
[TBL] [Abstract][Full Text] [Related]
19. NO-NSAIDs and cancer: promising novel agents.
Rigas B; Kalofonos H; Lebovics E; Vagenakis AG
Dig Liver Dis; 2003 May; 35 Suppl 2():S27-34. PubMed ID: 12846441
[TBL] [Abstract][Full Text] [Related]
20. Nitrates and NO-NSAIDs in cancer chemoprevention and therapy: in vitro evidence querying the NO donor functionality.
Dunlap T; Abdul-Hay SO; Chandrasena RE; Hagos GK; Sinha V; Wang Z; Wang H; Thatcher GR
Nitric Oxide; 2008 Sep; 19(2):115-24. PubMed ID: 18485921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
